The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 04, 2025

Filed:

Aug. 20, 2021
Applicant:

President and Fellows of Harvard College, Cambridge, MA (US);

Inventors:

David R. Liu, Cambridge, MA (US);

Alexis Christine Komor, Cambridge, MA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 9/22 (2006.01); A61K 38/46 (2006.01); A61K 38/50 (2006.01); A61K 47/61 (2017.01); C12N 9/64 (2006.01); C12N 9/78 (2006.01); C12N 15/01 (2006.01); C12N 15/10 (2006.01); C12P 19/34 (2006.01); C12Q 1/6883 (2018.01);
U.S. Cl.
CPC ...
C12N 9/22 (2013.01); A61K 38/465 (2013.01); A61K 38/50 (2013.01); A61K 47/61 (2017.08); C12N 9/6472 (2013.01); C12N 9/78 (2013.01); C12N 15/01 (2013.01); C12N 15/102 (2013.01); C12P 19/34 (2013.01); C12Q 1/6883 (2013.01); C12Y 301/00 (2013.01); C12Y 304/22062 (2013.01); C12Y 305/04 (2013.01); C12Y 305/04001 (2013.01); C12Y 305/04004 (2013.01); C12Y 305/04005 (2013.01); C07K 2319/00 (2013.01); C07K 2319/80 (2013.01); C12Q 2600/156 (2013.01); C12Y 301/22 (2013.01);
Abstract

Some aspects of this disclosure provide strategies, systems, reagents, methods, and kits that are useful for the targeted editing of nucleic acids, including editing a single site within the genome of a cell or subject, e.g., within the human genome. In some embodiments, fusion proteins of Cas9 and nucleic acid editing enzymes or enzyme domains, e.g., deaminase domains, are provided. In some embodiments, methods for targeted nucleic acid editing are provided. In some embodiments, reagents and kits for the generation of targeted nucleic acid editing proteins, e.g., fusion proteins of Cas9 and nucleic acid editing enzymes or domains, are provided.


Find Patent Forward Citations

Loading…